Group items tagged

U Xơ Cổ Tử Cung có thể gây nhiều biến chứng, thường gặp và nguy hiểm nhất là chảy máu. Không ít trường hợp ra máu rất nhiều khi hành kinh do khối u xơ cản trở sự co bóp của tử cung

U xơ cổ tử cung ở giai đoạn đầu thường phát triển âm thầm hầu như không có triệu chứng gì rõ rệt. Nhưng sau khi u xơ tử cung đã hình thành và bắt đầu gây ra ảnh hưởng thì chị em có thể nhận biết u xơ tử cung sớm nhất qua các dấu hiệu dưới đây.

Wegovy maker Novo Nordisk said on Tuesday (Aug 8) a large study had shown the highly effective obesity treatment also had a clear cardiovascular benefit, boosting the Danish company's hopes of moving beyond its image as a lifestyle drug. The increasingly popular Wegovy has transformed the weight-loss market since its U.S. launch in June 2021, capturing the attention of patients, investors and celebrities worldwide. Novo's news lifted shares in Europe's second-most valuable listed company after LVMH by more than 17 per cent to record highs. They have now surged almost 165 per cent over the past two years. The results of the late-stage trial may help persuade insurers in the U.S. and cost-conscious health authorities in Europe to cover the cost of Wegovy, which is $1,300 a month in the United States, for a wider range of patients. U.S. law classifies weight-loss treatments as lifestyle drugs and bars the Medicare health plan for older Americans from covering them and experts said the new data could lead the U.S. government to reassess that.

Weight loss drug Wegovy has transformed the obesity market and pharmaceutical companies with existing treatments are hoping the resulting demand will boost demand for their older, less effective but cheaper, drugs. A weekly injection of Wegovy, which was launched in the U.S. in June 2021, leads to an average weight loss of around 15%, alongside changes to diet and exercise. Its impact has captured the attention of patients, investors and even celebrities. But supply issues for Wegovy manufacturer Novo Nordisk means the Danish drugmaker has struggled to meet surging U.S. demand, delaying a launch in most of Europe. Insurers and some national governments have also baulked at its cost, while a minority of patients do not respond to it. Vivus and Currax Pharmaceuticals, U.S.-based developers whose treatments have been on the U.S. market for around a decade, hope to benefit from the attention and supply shortage. But scientists and investors say that lower efficacy plus side effects could continue to hold the treatments back.

U xơ tử cung là một bệnh lành tính nhưng cũng có thể gây nhiều biến chứng, nhất là các trường hợp được điều trị muộn.

Bệnh nhân U Xơ Cổ Tử Cung có thể vận động thích hợp, nhưng phải chú ý kết hợp làm việc và nghỉ ngơi, Tập thể dục điều độ có thể tăng sức đề kháng cho cơ thể

Đối với khối u có kích thước lớn hơn 5cm và đã có những ảnh hưởng chèn ép lên các cơ quan lân cận cần tiến hành phẫu thuật bằng các thủ thuật ngoại khoa để loại bỏ u xơ tử cung.

Bệnh u ơ tử cung tuy chưa xác định được nguyên nhân trực tiếp, nhưng các chuyên gia tin răng những tác động sau sẽ làm tăng nguy cơ mắc u xơ tử cung hơn : lối sống sinh hoạt và lối sống tình dục không lành mạnh, thay đổi nội tiết tố, mắc bệnh phụ khoa.

Để phát hiện sớm U xơ cổ tử cung cần dựa vào những biểu hiện thường gặp như Chảy máu kéo dài trong thời gian kinh nguyệt, lượng kinh có thể nhiều hoặc ít

Happy Birthday Wishes For Special Friend | Happy Birthday Wishes For Your Special Friend https://youtu.be/xaHhsY9JdpE ------------------------------------------------------------------------------------------------------ Support us by giving a thumbs up and Subscribe this channel https://www.youtube.com/channel/UCfCp... ----------------------------------------------------------------------------------------------------------- Full Collection of Unique and Amazing wishes videos https://www.youtube.com/channel/UCfCp... ------------------------------------------------------------------------------------------------- We Eleswhere:- Google Plus: https://plus.google.com/u/0/100086217... Facebook: https://web.facebook.com/wishesready/ Twitter: https://twitter.com/wishesready Linkedin: https://www.linkedin.com/in/wishesready/ Blogspot: https://wishesready.blogspot.com/ Tumblr: https://www.tumblr.com/blog/wishesready Plurk: https://www.plurk.com/Wishesready Pinterest: https://www.pinterest.com/wishesready/ scoop: http://www.scoop.it/u/wishesready Digg: http://digg.com/u/wishesready Medium: https://medium.com/@wishesready Myspace: https://myspace.com/wishesready Diigo: https://www.diigo.com/profile/wishesr... VK: https://vk.com/wishesready Stumbleupon: https://www.stumbleupon.com/stumbler/... ------------------------------------------------------------------------------------------------------- Please support us by Subscribing our Channel. Give us a thumbs up and comment below to show your love. Thank you for standing by!

The Scottish Medicines Consortium (SMC) has accepted AbbVie's RINVOQ (upadacitinib) for use within NHS Scotland for the treatment of adult patients with moderately to severely active ulcerative colitis (UC). Upadacitinib offers an additional treatment choice in the therapeutic class of janus kinase inhibitors. "Daily life with ulcerative colitis is difficult due to the debilitating and unpredictable nature of its symptoms", said Dr Jonathan Macdonald, Consultant Gastroenterologist at NHS Greater Glasgow and Clyde. "Clinical trials have shown that upadacitinib as a once daily pill controls symptoms in eight weeks for many patients and provided sustained responses at one year. The SMC's decision is good news for people with ulcerative colitis in Scotland as it provides an additional treatment option to help them gain control of their condition." The SMC decision is based on data from the induction studies U-ACHIEVE and U-ACCOMPLISH, as well as the Phase 3 U-ACHIEVE maintenance study, which demonstrated the efficacy of upadacitinib versus placebo in its ability to achieve clinical remission. The SMC's decision follows the granting of Marketing Authorisation for upadacitinib in UC in July 2022.

The U.S. durable medical equipment market size was valued at USD 52.9 billion in 2020. It is expected to expand at a compound annual growth rate (CAGR) of 6.0% over the forecast period.

Pandemic influenza wave that severely affected the U.S.A. cause viral infection in many people, this in an earlier period than traditionally high incidence in this country in late January and early February. As we know, the flu symptoms 2013 cause several deaths in the U.S. and spread to almost the entire country. Flu symptoms 2013 are quite severe and lead to some dangerous complications. That is why the body after ill health can be restored to the maximum, because, unfortunately, suffered from the new flu virus does not provide immunity against seasonal flu, nor other types of common viral infections.